| Trial registration number
|
NCT05252481 |
Full text link
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05252481
|
First author
Last imported at : July 8, 2022, midnight
Source : ClinicalTrials.gov
|
Jordi A Matias-Guiu
|
Contact
Last imported at : July 8, 2022, midnight
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
2022-02-23
|
Recruitment status
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
diagnosis of covid-19 with pcr-confirmation.
fatigue linked to covid-19
no diagnosis of neurological, psychiatric or medical disorder with potential impact on fatigue.
|
Exclusion criteria
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
stroke before covid-19
history of traumatic brain lesion or central nervous system infection previous to covid-19
radiotherapy or chemotherapy for cancer
severe sensorial deficits
drugs or uncontrolled medical disorder with potential impact on fatigue.
history of abuse of alcohol or other toxics.
any contraindication for tdcs (metallic implants, brain devices, pacemakers, head injuries).
|
Number of arms
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Hospital San Carlos, Madrid
|
Inclusion age min
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Spain
|
Type of patients
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Sept. 16, 2022, 2 a.m.
Source : ClinicalTrials.gov
|
47
|
primary outcome
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Change in Fatigue
|
Notes
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Feb. 24, 2022, 6:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1310, "treatment_name": "Transcranial direct-current stimulation", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|